News from the web:
The Alzheimer’s Reading Room is the number one source of life news and information for the entire Alzheimers and Dementia community. The goal of the Alzheimer’s Reading Room is to Educate, sometimes Entertain, and Empower Alzheimer’s caregivers, their families, and the entire Alzheimer’s community.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Maria Carrillo, a sr director at the Alzheimer association, provides a special at CNN about Alzheimer. She tells about the 5.4 Million American who live with Alzheimer’s disease and makes it personal by talking about her own mother in law who suffers from the disease.
She then goes on to talk about the National Plan to get Alzheimer’s disease under controle by 2025. The plan covers the spectrum of Alzheimer’s issues, including treatment and prevention, clinical care, support for families in their homes and communities as well as public education and engagement.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
The clock is ticking: The first National Alzheimer’s Plan sets a deadline of 2025 to finally find effective ways to treat, or at least stall, the mind-destroying disease.
The Obama administration finalizes the landmark national strategy on Tuesday, laying out numerous steps the government and private partners can take over the coming years to fight what is poised to become a defining disease of the rapidly aging population.
But some of the work is beginning right away.
Starting Tuesday, embattled families and caregivers can check a new one-stop website — www.alzheimers.gov — for easy-to-understand information about dementia and where to get help in their own communities.
The National Institutes of Health is funding some major new studies of possible therapies, including a form of insulin that’s squirted into the nose.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
The former farm worker tried to rip out the Taser darts before officers reportedly tied up his arms and legs.
Humberside Police said the controversial electronic weapon was used because Mr Russell refused to be sectioned under the Mental Health Act.
His wife Diane, 50, slammed cops for using Tasers on her husband and is threatening to launch a formal complaint.
She said her husband was left traumatised by the incident in Epworth, Lincs.
The mum of two added: “There was no need to use the Taser.
“If he was a wife beater or an armed robber then I could understand it but this is someone who will stop his tractor when ploughing a field and move a nest of mice to the side.”
Mrs Russell, who spoke out to prevent other families from going through the same ordeal, said her husband became agitated when police came to assist doctors with his transfer to hospital.
She told The Daily Mail: “He was fighting them off because he didn’t want to go. He was petrified and scared. I remember saying, ‘It’s the Alzheimer’s.’
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Anders Lönneborg, PhD, has been chosen as the recipient of the 2012 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on the detection of early Alzheimer’s disease.
“My co-authors and I are extremely pleased to have been chosen by a distinguished group of peers as the recipients of this year’s Journal of Alzheimer’s Disease award for our work on the development of ADtect®, the 96-gene expression test for detection of early Alzheimer’s disease,” said Dr. Lönneborg, Research Director, DiaGenic, Oslo, Norway.
Each year the more than 500 Associate Editors of the Journal of Alzheimer’s Diseasevote to select an outstanding article published the previous year to receive this prestigious award, which is made possible by support from IOS Press and Elan Pharmaceuticals. Dr. Lönneborg will be presented with the bronze Alzheimer Medal featuring the likeness of Alois Alzheimer. The winning paper is entitled, “A Novel Blood Test for the Early Detection of Alzheimer’s Disease” (J Alzheimers Dis 23, 121-129, 2011), by A. Lönneborg et al.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Amyvid is a radiopharmaceutical developed by the Eli Lilly Company to aid in the diagnosis of Alzheimer’s disease by causing previously invisible beta amyloid plaque deposits in the brain to show up in PET scans. The FDA has recently approved Amyvid for clinical use although its use remains somewhat controversial.
Dr. Alois Alzheimer’s discovery of the physical changes in the brain in the early 1900s has caused researchers to focus on the plaque deposits he found in autopsied brains of diseased patients. If the plaque causes the disease, discovering the plaque before a patient’s symptoms worsen could mean closing in on a cure.
Read all about it HERE
visit us at AlzheimerHeadlines.com